Doctors at OhioHealth Mansfield Hospital celebrated their 500th procedure to help reduce the risk of stroke in patients with ...

The global left atrial appendage closure device market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 8.7 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

The global left atrial appendage closure device market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 8.7 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Atrial fibrillation recurrence after catheter ablation was not significantly linked to major adverse outcomes, regardless of ...

Your dentist's warnings about flossing aren't just about preventing bad breath and cavities. New research from Japan reveals ...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Left Atrial Appendage Closure (LAAC) Market - A Global and Regional Analysis: Focus on Procedure, Product, End User, and Region - Analysis and Forecast, ...

Pompeu Fabra University (UPF) and the Royal Veterinary College of London have worked together on a pioneering project worldwide to generate 3D ...

A Jacksonville cardiologist weighs in on groundbreaking treatment for AFib and future innovations at Ascension St. Vincent's Riverside.

Pompeu Fabra University (UPF) and the Royal Veterinary College of London have worked together on a pioneering project ...

New data finds women 8% more likely to experience major complications after transcatheter aortic valve implantation (TAVI) ...

Analysts have set 12-month price targets for AtriCure, revealing an average target of $52.5, a high estimate of $66.00, and a low estimate of $44.00. Marking an increase of 2.94%, the current average ...